9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Annual Report to Security Holders
Financial Results, Press Release
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Announces Positive Top-Line Results from Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
News
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Definitive Revised Proxy Statement
Submission Upload
Correspondence